Entering text into the input field will update the search result below

Vanda Pharmaceuticals beats by $0.09, beats on revenue

Aug. 07, 2014 7:45 AM ETVanda Pharmaceuticals Inc. (VNDA) StockBy: Gaurav Batavia, SA News Editor
  • Vanda Pharmaceuticals (NASDAQ:VNDA): Q2 EPS of -$0.64 beats by $0.09.
  • Revenue of $10.9M (+31.0% Y/Y) beats by $0.9M.
  • Press Release

Recommended For You

More Trending News

About VNDA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VNDA--
Vanda Pharmaceuticals Inc.